FR2498187B1 - - Google Patents

Info

Publication number
FR2498187B1
FR2498187B1 FR8100765A FR8100765A FR2498187B1 FR 2498187 B1 FR2498187 B1 FR 2498187B1 FR 8100765 A FR8100765 A FR 8100765A FR 8100765 A FR8100765 A FR 8100765A FR 2498187 B1 FR2498187 B1 FR 2498187B1
Authority
FR
France
Prior art keywords
formula
carbon atoms
optionally substituted
amino
dialkylamino group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8100765A
Other languages
English (en)
French (fr)
Other versions
FR2498187A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Priority to FR8100765A priority Critical patent/FR2498187A1/fr
Priority to JP57003535A priority patent/JPS57171973A/ja
Priority to DK16582A priority patent/DK148805C/da
Priority to IN36/DEL/82A priority patent/IN158327B/en
Priority to AT82400080T priority patent/ATE7492T1/de
Priority to KR8200161A priority patent/KR870001921B1/ko
Priority to IE75/82A priority patent/IE51957B1/en
Priority to EP82400080A priority patent/EP0056766B1/fr
Priority to CA000394273A priority patent/CA1171861A/fr
Priority to DE8282400080T priority patent/DE3260150D1/de
Priority to US06/339,722 priority patent/US4421920A/en
Priority to HU82121A priority patent/HU184985B/hu
Priority to ZA82277A priority patent/ZA82277B/xx
Publication of FR2498187A1 publication Critical patent/FR2498187A1/fr
Application granted granted Critical
Publication of FR2498187B1 publication Critical patent/FR2498187B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/46Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR8100765A 1981-01-16 1981-01-16 Procede de preparation d'amino-4 chloro-7 quinoleines Granted FR2498187A1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR8100765A FR2498187A1 (fr) 1981-01-16 1981-01-16 Procede de preparation d'amino-4 chloro-7 quinoleines
JP57003535A JPS57171973A (en) 1981-01-16 1982-01-14 Manufacture of 4-amino-chloroquinolines
DE8282400080T DE3260150D1 (en) 1981-01-16 1982-01-15 Process for the preparation of 4-amino-chloroquinolines
AT82400080T ATE7492T1 (de) 1981-01-16 1982-01-15 Verfahren zur herstellung von 4-aminochlorchinolinen.
KR8200161A KR870001921B1 (ko) 1981-01-16 1982-01-15 4-이미노-클로로키놀린의 제조방법
IE75/82A IE51957B1 (en) 1981-01-16 1982-01-15 Process for the preparation of 4-amino-chloroquinolines
DK16582A DK148805C (da) 1981-01-16 1982-01-15 Fremgangsmaade til fremstilling af 4-aminochlorquinoliner
CA000394273A CA1171861A (fr) 1981-01-16 1982-01-15 Procede de preparation d'amino-4 chloro-7 quinoleines
IN36/DEL/82A IN158327B (enExample) 1981-01-16 1982-01-15
US06/339,722 US4421920A (en) 1981-01-16 1982-01-15 Process for the preparation of 4-amino-chloroquinolines
HU82121A HU184985B (en) 1981-01-16 1982-01-15 Process for producing 4-amino-chloroquinolines
ZA82277A ZA82277B (en) 1981-01-16 1982-01-15 4-amino-chloroquinolines
EP82400080A EP0056766B1 (fr) 1981-01-16 1982-01-15 Procédé de préparation d'amino-4 chloroquinoléines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8100765A FR2498187A1 (fr) 1981-01-16 1981-01-16 Procede de preparation d'amino-4 chloro-7 quinoleines

Publications (2)

Publication Number Publication Date
FR2498187A1 FR2498187A1 (fr) 1982-07-23
FR2498187B1 true FR2498187B1 (enExample) 1983-09-30

Family

ID=9254223

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8100765A Granted FR2498187A1 (fr) 1981-01-16 1981-01-16 Procede de preparation d'amino-4 chloro-7 quinoleines

Country Status (13)

Country Link
US (1) US4421920A (enExample)
EP (1) EP0056766B1 (enExample)
JP (1) JPS57171973A (enExample)
KR (1) KR870001921B1 (enExample)
AT (1) ATE7492T1 (enExample)
CA (1) CA1171861A (enExample)
DE (1) DE3260150D1 (enExample)
DK (1) DK148805C (enExample)
FR (1) FR2498187A1 (enExample)
HU (1) HU184985B (enExample)
IE (1) IE51957B1 (enExample)
IN (1) IN158327B (enExample)
ZA (1) ZA82277B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2892298A (en) * 1957-08-05 1959-06-30 Earl J Chaney Pickup device
GB8426584D0 (en) * 1984-10-19 1984-11-28 Beecham Group Plc Compounds
EP0222839A4 (en) * 1985-05-17 1988-11-09 Univ Australian ANTI-MALARIA COMPOUNDS.
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
CA1340821C (en) * 1988-10-06 1999-11-16 Nobuyuki Fukazawa Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
CA2133620A1 (en) * 1993-10-28 1995-04-29 Werner Hofheinz Aminoquinoline derivatives
AU6168296A (en) * 1995-06-07 1996-12-30 The Administrators Of The Tulane Eductional Fund Chloroquine analogs and methods of preventing and treating p lasmodial disease
KR100489174B1 (ko) 1996-03-05 2005-09-30 제네카-파마 소시에떼아노님 4-아닐리노퀴나졸린유도체
IL128994A (en) * 1996-09-25 2004-12-15 Zeneca Ltd History of quinoline and naphthyridine and their salts, processes for their preparation, pharmaceutical preparations containing them and their use as medicines
GB9910579D0 (en) 1999-05-08 1999-07-07 Zeneca Ltd Chemical compounds
GB9910580D0 (en) 1999-05-08 1999-07-07 Zeneca Ltd Chemical compounds
US6417177B1 (en) 1999-07-13 2002-07-09 Alpha Research Group, Llc Chloroquine derivatives for the treatment of Parkinson's disease
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
PT1274692E (pt) * 2000-04-07 2006-11-30 Astrazeneca Ab Compostos de quinazolina
EP1337524A1 (en) * 2000-11-02 2003-08-27 AstraZeneca AB Substituted quinolines as antitumor agents
JP2004517059A (ja) * 2000-11-02 2004-06-10 アストラゼネカ アクチボラグ 抗腫瘍剤用の4−置換キノリン類
US7084157B2 (en) * 2002-05-17 2006-08-01 Rajeev Raut Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation
US20040002451A1 (en) * 2002-06-20 2004-01-01 Bruce Kerwin Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
GB0215823D0 (en) * 2002-07-09 2002-08-14 Astrazeneca Ab Quinazoline derivatives
GB0225579D0 (en) * 2002-11-02 2002-12-11 Astrazeneca Ab Chemical compounds
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
US7108992B2 (en) * 2002-11-27 2006-09-19 St. Jude Children's Research Hospital ATM kinase compositions and methods
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
KR101218213B1 (ko) 2003-07-03 2013-01-04 시토비아 인크. 카스파제의 활성인자 및 세포자멸사의 유도인자로서의4-아릴아미노-퀴나졸린
GEP20084572B (en) * 2003-12-23 2008-12-25 Pfizer Novel quinoline derivatives
ES2237332B1 (es) 2004-01-14 2006-11-01 Consejo Sup. Investig. Cientificas Derivados de piridinio y quinolinio.
US8586613B2 (en) 2004-01-14 2013-11-19 Universidad De Granada Pyridinium and quinolinium derivatives
EP1833482A4 (en) 2005-01-03 2011-02-16 Myriad Genetics Inc COMPOUNDS AND ITS THERAPEUTIC USE
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
WO2007059372A2 (en) * 2005-11-09 2007-05-24 St. Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
CN105693605B (zh) * 2016-03-09 2017-12-22 西安科技大学 一种光学纯(r)/(s)‑氯喹的不对称合成方法
CN105693606B (zh) * 2016-03-09 2017-12-05 西安科技大学 一种光学纯(r)/(s)‑羟氯喹的不对称合成方法
EP4251746A1 (en) 2020-11-30 2023-10-04 Cellectis SA Use of aminoquinoline compounds for higher gene integration
CN115947684B (zh) * 2023-01-18 2025-01-17 贵州医科大学 一种钯和铜协同催化氧化芳构化制备4-胺基喹啉类衍生物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2653940A (en) * 1951-01-27 1953-09-29 William S Johnson Process for preparing 4-quinolyl secondary amines

Also Published As

Publication number Publication date
ZA82277B (en) 1982-11-24
HU184985B (en) 1984-11-28
EP0056766A1 (fr) 1982-07-28
FR2498187A1 (fr) 1982-07-23
CA1171861A (fr) 1984-07-31
IN158327B (enExample) 1986-10-18
DK16582A (da) 1982-07-17
IE51957B1 (en) 1987-04-29
KR870001921B1 (ko) 1987-10-22
IE820075L (en) 1982-07-16
ATE7492T1 (de) 1984-06-15
DE3260150D1 (en) 1984-06-20
KR830009038A (ko) 1983-12-17
DK148805C (da) 1986-04-01
US4421920A (en) 1983-12-20
DK148805B (da) 1985-10-07
JPS57171973A (en) 1982-10-22
EP0056766B1 (fr) 1984-05-16

Similar Documents

Publication Publication Date Title
FR2498187B1 (enExample)
GB2185252B (en) Triazole derivatives
GR79637B (enExample)
ZA858169B (en) New adamantanamine derivatives,processes for their preparation and drugs in which they are present
ES511753A0 (es) Un procedimiento para la preparacion de derivados de sucrosa'4-halo-sustituidos.
GR3018629T3 (en) Piperidine compounds with glycosidase inhibition activity.
ATE87307T1 (de) Isoindolinderivate und verfahren zu ihrer herstellung.
FR2498607B1 (enExample)
IL113451A0 (en) A proces for the preparation of 5, 6 - dihydroxy -2- amino - 1, 2, 3, 4 - tetrahydronaphthalene derivatives
JPS57185280A (en) 5-(4-phenyl-1-piperidinyl)methyl-2,3-dihydro- 2-oxo-1h-imidazole-4-carboxylic acid derivatives
IE810260L (en) Benzylidene derivatives.
ES481486A1 (es) Procedimientos para preparar derivados de acidos 1-pirrol- carboxilixos
IL65667A (en) 4-(4-phenyl-1-piperidinyl)methyl-5-benzoyl-1,3-dihydro-2h-imidazol-2-one derivatives and process for their preparation
IL65666A0 (en) 4-aminomethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
ES8305732A1 (es) Procedimiento para preparar derivados de imidazol.
IE792347L (en) Benzimidazole derivatives.
FI874677A0 (fi) Laekemedel anvaendbart vid behandling av magsaor.

Legal Events

Date Code Title Description
ST Notification of lapse